Biotech 2050 Podcast
121. Mission-driven biotech investing, Josh Wolfe, Co-founder & Managing Partner, Lux Capital
over 2 years ago
120. Beyond CD8 immuno-oncology, Amanda Wagner, President and CEO, Immunitas Therapeutics
over 2 years ago
118. One team, one mission: tackling pruritus, Chris Posner, President & CEO, Cara Therapeutics
over 2 years ago
116. Retinal restoration and visions for growth, Brian Culley, CEO, Lineage Cell Therapeutics
over 2 years ago
115. Innovations in diabetes therapies, Timothy Kieffer, CSO, Manasi Sinha Jaiman, CMO, ViaCyte
over 2 years ago
114. Advancing cell therapy and multiple myeloma treatment, Ying Huang, CEO, Legend Biotech
over 2 years ago